STOCKWATCH
·
Biotechnology: Laboratory Analytical Instruments
Quarterly ResultMay 7, 2026, 04:42 PM

Mettler-Toledo Q1 Sales +7% to $947.1M; Adjusted EPS +9% to $8.91

AI Summary

Mettler-Toledo International Inc. reported strong first-quarter 2026 results, with reported sales increasing 7% to $947.1 million and Adjusted EPS growing 9% to $8.91. The company delivered good performance despite an increasingly uncertain market, supported by solid execution of margin initiatives. Management also raised its full-year 2026 Adjusted EPS guidance to a range of $46.30 to $46.95, representing 8% to 10% growth.

Key Highlights

  • Reported sales increased 7% to $947.1 million in Q1 2026.
  • Adjusted EPS rose 9% to $8.91, compared to $8.19 in the prior-year period.
  • Local currency sales increased 3%, with 1% growth excluding acquisitions.
  • Reported sales grew 12% in Europe, 8% in Asia/Rest of World, and 3% in Americas.
  • Adjusted Operating Profit increased 4% to $246.2 million.
  • Full-year 2026 Adjusted EPS guidance raised to $46.30-$46.95 (8-10% growth).
  • Q2 2026 Adjusted EPS forecast at $10.70-$10.85 (6-8% growth).
MTD
Biotechnology: Laboratory Analytical Instruments
METTLER TOLEDO INTERNATIONAL INC/

Price Impact